Limited impact of COVID-19-related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis.
Tobias E SangersMarlies WakkeeEline C Kramer-NoelsTamar E C NijstenMarieke W J LouwmanElisabeth H JasparsLoes M HollesteinPublished in: The British journal of dermatology (2022)
To date, the diagnostic delay caused by COVID-19 has not resulted in relatively more unfavourable primary tumour characteristics of melanoma or cSCC. Follow-up studies in the coming years are needed to identify a potential impact on staging distribution and survival in the long term.